Who owns CASI PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Casi Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Casi Pharmaceuticals stock

Who bought or sold CASI PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
VR Adviser 987k $1.6M 0% Sep 2025
 View chart
Foresite Capital Management VI 980k $1.6M 24% Sep 2025
 View chart
Woodline Partners 166k $275k 0% Sep 2025
 View chart
Wellington Shields Capital Management 70k $115k -23% Sep 2025
 View chart
Renaissance Technologies 44k $73k 12% Sep 2025
 View chart
Two Sigma Investments 33k $55k 100% Sep 2025
 View chart
Wellington Shields & Co 30k $50k 0% Sep 2025
 View chart
Geode Capital Management 19k $31k 0% Sep 2025
 View chart
Ground Swell Capital 10k $17k 100% Sep 2025
 View chart
Royal Bank of Canada 10k $0 0% Sep 2025
 View chart
Group One Trading 2.3k $3.8k 100% Sep 2025
 View chart
Wells Fargo & Company 505.00 $837.997000 0% Sep 2025
 View chart
Morgan Stanley 365.00 $431.649000 100% Jun 2025
 View chart
BlackRock 296.00 $491.004800 0% Sep 2025
 View chart
Simplex Trading 145.00 $0 458% Sep 2025
 View chart
Bnp Paribas Arbitrage, Snc 134.00 $221.997800 0% Sep 2025
 View chart
Jpmorgan Chase & Co 25.00 $42.000000 0% Sep 2025
 View chart
UBS Group 14.00 $23.000600 -99% Sep 2025
 View chart
Northwestern Mutual Wealth Management Company 13.00 $21.999900 0% Sep 2025
 View chart
Colonial Trust Co / SC 11.00 $18.000400 0% Sep 2025
 View chart
MAI Wealth Advisors 5.00 $9.000000 0% Sep 2025
 View chart

Who sold out of Casi Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
ADAR1 Capital Management Jun 2025 44k $52k
Citadel Advisors Jun 2025 36k $43k
Two Sigma Securities Jun 2025 12k $14k
Susquehanna International Jun 2025 10k $12k